Intuitive Surgical (ISRG) Cash from Financing Activities (2009 - 2026)
Intuitive Surgical (ISRG) posted Cash from Financing Activities of -$287.9 million for Q2 2026, up 78.73% on a QoQ basis from -$1.4 billion in Q1 2026, and down 94.79% year-over-year from -$5.5 billion in Q2 2025.
Analysis
Intuitive Surgical (ISRG) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Intuitive Surgical has reported Cash from Financing Activities for 18 years, with the latest figure at -$287.9 million in Q2 2026.
- On a quarterly basis, Cash from Financing Activities fell 94.79% year-over-year to -$287.9 million in Q2 2026; TTM through Jun 2026 was -$3.6 billion, a 1434.79% decrease from a year earlier, with the FY2025 full-year figure at -$2.4 billion, down 1666.67% from the prior year.
- Cash from Financing Activities was -$287.9 million for Q2 2026 at Intuitive Surgical, up from -$1.4 billion in the prior quarter.
- The five-year high for Cash from Financing Activities was $98.2 million in Q3 2024, with the low at -$1.8 billion in Q3 2025.
- Average Cash from Financing Activities over 5 years is -$373.0 million, with a median of -$173.8 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities plunged 5280.11% in 2022, then soared 256.83% in 2024.
- Over 5 years, Cash from Financing Activities stood at -$963.5 million in 2022, then surged by 96.73% to -$31.5 million in 2023, then jumped by 256.83% to $49.4 million in 2024, then plunged by 378.34% to -$137.5 million in 2025, then tumbled by 109.38% to -$287.9 million in 2026.
- The last three Cash from Financing Activities figures came in at -$287.9 million (Q2 2026), -$1.4 billion (Q1 2026), and -$137.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Zimmer Biomet Holdings | 18.00 Bn | 17.59 Bn | 1.54 Bn | -271.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -287.90 Mn |
| Mar 31, 2026 | -1.35 Bn |
| Dec 31, 2025 | -137.50 Mn |
| Sep 30, 2025 | -1.84 Bn |
| Jun 30, 2025 | -147.80 Mn |
| Mar 31, 2025 | -235.80 Mn |
| Dec 31, 2024 | 49.40 Mn |
| Sep 30, 2024 | 98.20 Mn |
| Jun 30, 2024 | 50.00 Mn |
| Mar 31, 2024 | -46.70 Mn |
| Dec 31, 2023 | -31.50 Mn |
| Sep 30, 2023 | 61.80 Mn |
| Jun 30, 2023 | 63.30 Mn |
| Mar 31, 2023 | -381.20 Mn |
| Dec 31, 2022 | -963.50 Mn |
| Sep 30, 2022 | -926.80 Mn |
| Jun 30, 2022 | -482.10 Mn |
| Mar 31, 2022 | -199.90 Mn |
| Dec 31, 2021 | 18.60 Mn |
| Sep 30, 2021 | 68.30 Mn |